Balchem Q1 2026 net sales rise 8.1% to $270.7 million; GAAP EPS $1.25
Balchem Corporation reported first quarter 2026 results for the period ended March 31, 2026, with net sales up 8.1% and GAAP net earnings up 8.7% from the prior year quarter. Sales and earnings from operations grew in all three reporting segments, and the company reported strong cash flow, though the filing gives no full-year guidance.
Key points
- Net sales were $270.7 million, up from $250.5 million in the first quarter of 2025.
- GAAP net earnings were $40.3 million, and diluted EPS was $1.25 versus $1.13 a year earlier.
- Adjusted EPS was $1.33 versus $1.22; free cash flow was $33.8 million.
- Results were released April 30, 2026, with a conference call the same day at 11:00 AM ET.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:05 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 30, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.